Page last updated: 2024-10-25

cilostazol and Hemorrhagic Stroke

cilostazol has been researched along with Hemorrhagic Stroke in 2 studies

Hemorrhagic Stroke: Stroke due to rupture of a weakened blood vessel in the brain (e.g., CEREBRAL HEMISPHERES; CEREBELLUM; SUBARACHNOID SPACE).

Research Excerpts

ExcerptRelevanceReference
" Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel."8.31Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023)
"Continuous treatment of cilostazol in patients with HD with PAD significantly decreases the risk of ED visits, hemorrhagic stroke, and cardiovascular events and improves ED visit-free and cardiovascular event-free rates during long-term follow-up."4.31Long-Term Effectiveness of Cilostazol in Patients with Hemodialysis with Peripheral Artery Disease. ( Chen, YY; Kao, ZK; Lin, CH; Wu, CK; Yang, YB; Yar, N, 2023)
" Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel."4.31Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wu, CK1
Lin, CH1
Yar, N1
Kao, ZK1
Yang, YB1
Chen, YY1
Lee, YJ1
Je, NK1

Other Studies

2 other studies available for cilostazol and Hemorrhagic Stroke

ArticleYear
Long-Term Effectiveness of Cilostazol in Patients with Hemodialysis with Peripheral Artery Disease.
    Journal of atherosclerosis and thrombosis, 2023, Aug-01, Volume: 30, Issue:8

    Topics: Adult; Cilostazol; Hemorrhagic Stroke; Humans; Ischemic Stroke; Peripheral Arterial Disease; Platele

2023
Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.
    European journal of clinical pharmacology, 2023, Volume: 79, Issue:8

    Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhagi

2023